Stimulator, pump and composition
Described is a low voltage, pulsed electrical stimulation device for controlling expression of, for example, follistatin, a muscle formation promotion protein, by tissues. Epicardial stimulation is especially useful for heart treatment. Follistatin controlled release is also useful for treating other ailments, such as erectile dysfunction, aortic aneurysm, and failing heart valves.
1. A system for stimulating a target tissue in a subject, the system comprising:
a bioelectric stimulator programmed to produce bioelectric signals that stimulate the target tissue to express and/or release stromal cell-derived factor 1 (“SDF-1”) and platelet-derived growth factor (“PDGF”),
wherein the bioelectric signal to produce SDF-1 comprises:
30 pulses per second with a voltage of 3.5 mV, and successively alternating currents of 700 to 1500 picoamps for one minute, and again with 700 to 1500 picoamps for one minute, plus stimulated with a current of 0.25 mA, pulse duration of 40 pulses per second, pulse width of 100 μs, and frequency of 100 Hz, each signal for 40 minutes to 8 hours a day, and
wherein the bioelectric signal to produce PDGF comprises:
3 V/cm, 10 Hz, 2 μA (0.000002 amps), and pulse duration of 0.2 ms, or 20 V/cm, 100 Hz, 0.25 μA (2.5e-7 amps), and pulse duration of 40 pulses/s, width of 100 μs; and
a microinfusion pump for continuous or repeat delivery of a liquid composition to the target tissue.
2. The system of claim 1 , wherein the microinfusion pump is programmable.
3. The system of claim 1 , wherein the microinfusion pump is re-fillable with low cell damage to the subject.
4. The system of claim 3 , wherein the microinfusion pump includes silicon septum ports and associated reservoir chambers for the liquid composition.
5. The system of claim 1 , wherein the microinfusion pump comprises a refilling silicon septum port and reservoir chamber for the liquid composition.
6. The system of claim 5 , wherein the liquid composition further comprises muscle-derived stem cells.
7. The system of claim 1 , wherein the liquid composition comprises adipose-derived stem cells, exosomes, MicroRNAs, nutrient hydrogel, growth factor cocktail, alkaloids, and an anti-inflammatory agent.
8. A method of using the system of claim 1 to stimulate tissue of a subject, the method comprising:
connecting the bioelectric stimulator and microinfusion pump to the target tissue and providing stimulation to the target tissue.
9. The method of claim 8 , wherein the connection is via conductive soft wrap.
10. The system of claim 1 , wherein the bioelectric stimulator is further programmed to produce a bioelectric signal of 200 picoamps for 10 seconds for one (1) hour with a pulse having an amplitude of 5 volts and a width of 0.5 milliseconds for one (1) hour.
11. The system of claim 1 , wherein the microinfusion pump is configured for repeat delivery of the liquid composition to the target tissue.
12. A system for stimulating a target tissue in a subject, the system comprising:
a bioelectric stimulator programmed to produce bioelectric signals that stimulate the target tissue to express and/or release stromal cell-derived factor 1 (“SDF-1”) and platelet-derived growth factor (“PDGF”),
wherein the bioelectric signal to produce SDF-1 comprises:
30 pulses per second with a voltage of 3.5 mV, and successively alternating currents of 700 to 1500 picoamps for one minute, and again with 700 to 1500 picoamps for one minute, plus stimulated with a current of 0.25 mA, pulse duration of 40 pulses per second, pulse width of 100 μs, and frequency of 100 Hz, each signal for 40 minutes to 8 hours a day, and
wherein the bioelectric stimulator is further programmed to produce a bioelectric signal of 10V at 50 HZ and 100 Hz, 0.25 mA for one (1) minute; and
a microinfusion pump for continuous or repeat delivery of a liquid composition to the target tissue.
13. A system for stimulating a target tissue in a subject, the system comprising:
a bioelectric stimulator programmed to produce bioelectric signals that stimulate the target tissue to express and/or release stromal cell-derived factor 1 (“SDF-1”) and platelet-derived growth factor (“PDGF”),
wherein the bioelectric signal to produce SDF-1 comprises:
30 pulses ver second with a voltage of 3.5 mV, and successively alternating currents of 700 to 1500 picoamps for one minute, and again with 700 to 1500 picoamps for one minute, plus stimulated with a current of 0.25 mA, pulse duration of 40 pulses per second, pulse width of 100 s, and frequency of 100 Hz, each signal for 40 minutes to 8 hours a day, and
wherein the bioelectric stimulator is further programmed to produce a bioelectric signal of 0.06 V with 50 Hz alternating electrical field and electric current of 1 mA for 15 minutes and 3 mA for 15 minutes; and
a microinfusion pump for continuous or repeat delivery of a liquid composition to the target tissue.
14. A system for stimulating a target tissue in a subject, the system comprising:
a bioelectric stimulator programmed to produce bioelectric signals that stimulate the target tissue to express and/or release stromal cell-derived factor 1 (“SDF-1”) and platelet-derived growth factor (“PDGF”),
wherein the bioelectric signal to produce SDF-1 comprises:
30 pulses ver second with a voltage of 3.5 mV, and successively alternating currents of 700 to 1500 picoamps for one minute, and again with 700 to 1500 picoamps for one minute, plus stimulated with a current of 0.25 mA, pulse duration of 40 pulses per second, pulse width of 100 μs, and frequency of 100 Hz, each signal for 40 minutes to 8 hours a day, and
wherein the bioelectric stimulator is further programmed to produce a bioelectric signal applied to the target tissue of 3 mV with electric frequency of 22 Hz, and current of 1 mA for 15 minutes and 3 mA for 15 minutes; and
a microinfusion pump for continuous or repeat delivery of a liquid composition to the target tissue.